A recent Bloomberg Big Take by Anna Edney and Riley Griffin reveals growing tensions within the U.S. government over drug safety, with concerns that the FDA is failing to adequately oversee a global, low-cost generic drug supply chain.

Amid these concerns, U.S. Army Colonel Victor Suarez partnered with Valisure to test the quality of critical medications used by combat troops. The results were alarming—some generics may be ineffective or dangerous, with risks including kidney failure and seizures.

The article frames generic drug quality as not only a healthcare issue, but a national security threat—a view increasingly shared by the White House, Congress, and the Department of Defense.

Read the full article via Bloomberg here.

‍

A recent Bloomberg Big Take by Anna Edney and Riley Griffin reveals growing tensions within the U.S. government over drug safety, with concerns that the FDA is failing to adequately oversee a global, low-cost generic drug supply chain.

Amid these concerns, U.S. Army Colonel Victor Suarez partnered with Valisure to test the quality of critical medications used by combat troops. The results were alarming—some generics may be ineffective or dangerous, with risks including kidney failure and seizures.

The article frames generic drug quality as not only a healthcare issue, but a national security threat—a view increasingly shared by the White House, Congress, and the Department of Defense.

Read the full article via Bloomberg here.

‍